Investing in palliative and end-of-life care services improves our chances of living well towards the end of life, and in accordance with our wishes. However, the global provision of palliative and end-of-life care is hampered by the absence of health economics research demonstrating value for money. 1 Despite increasing interest in the economics of palliative and end-of-life care, research into priority setting, costs and outcomes, supply and demand, the planning and funding of services, economic evaluation and broader health system analysis in this setting is relatively scarce.
This Special Issue of Palliative Medicine aims to explore the many economic facets of providing and funding palliative and end-of-life care. While the call for papers sought a wide variety of topics and methods, the vast majority of papers submitted to, and accepted for, the special issue concern the costs of palliative and end-of-life care. These include a number of important papers covering challenging issues around capturing accurate data in a complex area; measuring costs in palliative and end-of-life care is notoriously difficult. 2, 3 These costing papers advance our understanding of resource use in a number of ways. Gardiner et al., 4 through systematic review of existing evidence, highlight the predominance of hospital costing as an approach, while Rowland and colleagues 5 complement this work by filling some of the gaps found by Gardiner et al. They estimate the economic value of family caregivers' contributions to inform future modelling and funding studies. There are also important contributions in terms of resource impacts for non-cancer populations from Dzingina et al. 6 and Van der Plas et al., 7 highlighting the imperative to focus on these non-cancer populations and, in the case of Dzingina et al., highlighting the substantial contribution of informal care to the total costs. Informal care costs are also highlighted by Brick et al. 8 The final costing paper in the issue from May et al. 9 provides new insights into what drives financial savings associated with hospital-based palliative care consultation relative to usual care, suggesting the importance of both shorter lengths of stay and reduced treatment intensity. These papers are all valuable contributions, but the heavy weighting within the special issue towards papers focusing exclusively on costs highlights major concerns with the current literature on the economics of palliative and end-of-life care.
Just one paper in this issue 10 focuses on the methodologically complex and highly disputed area of how to measure outcomes for economic evaluation of palliative and end-oflife interventions. [11] [12] [13] [14] Although the paper from Wichmann and colleagues provides a helpful summary of the current state of the literature, it does not advance the work in this area, meaning that there are no papers in this Special Issue that provide a new contribution to the study of outcomes. Yet for strong economic evaluations that can determine the relative efficiency of different interventions, both cost and outcome data are required. We would therefore suggest that more equal weighting of effort is required from those working within the area of economic evaluation within palliative and end-of-life care so that the literature can move on from descriptions of costs to analyses of efficiency. Further work in the areas of quality-adjusted life year (QALY) measurement, capability measurement, the suggested Palliative Care Yardstick (PalY), discrete choice experiments and other innovative methods, such as multiple outcomes costeffectiveness analysis, 15 would all be welcome developments. There are also important issues around people's preferences for time spent in particular end-of-life states that need considerably more attention in measuring the benefits of palliative and end-of-life interventions.
The special issue also highlights the relative paucity of the literature going beyond micro-level assessments of costs and benefits. Just one paper in the issue focuses on broader issues, with the paper by Murtagh et al. 16 providing, for the first time, a valuable description of international palliative care funding models. One of the major challenges for funders and decision-makers when examining the evidence to inform the development of new palliative and end-of-life care service models is the limited generalisability of the results of economic analyses from one jurisdiction to another. Palliative care is a complex disease area; aetiology, symptoms, treatment and needs are multi-faceted requiring a broad range of services provided by diverse disciplines across all health care sectors. Furthermore, services are influenced by location, culture and historical funding. 3 Therefore, context is vital when applying findings from one jurisdiction to another. The paper from Murtagh and colleagues clearly illustrates the diverse systems and settings, and their influence on what care is available to whom. Little is known about the relative costs and benefits of alternative ways of providing 695677P MJ0010.1177/0269216317695677Palliative MedicineEditorial editorial2017 Editorial Palliative Medicine 31 (4) care in different settings and whether the service models currently funded are the most efficient use of resources. It is clear that much more health economics research needs to focus on issues beyond economic evaluation, to facilitate national and international comparisons and to determine how the learning from one jurisdiction can be applied to another, avoiding the reinvention of the wheel.
There are also many important topics within health economics where there were no substantive contributions to this Special Issue and where economics could have a valuable input. Two of these, in particular, are the distributional issues around the equity and fairness of provision, and the use of economic incentives to improve and enhance service provision.
As demands and financial pressures on health and social care systems continue to rise, we need to better understand how best to invest limited resources to maximise the value of palliative and end-of-life care to individuals, informal caregivers, clinicians and societal decision-makers. 17 While articles published in this special edition of Palliative Medicine start to fill some of the knowledge gaps, there is much still to do, and the special issue taps only a small area of economics. The area of end of life lags behind much of health care in the extent of the economics contribution, and that needs to change. This requires some level of cultural change, both from economists who need greater willingness to engage with this more complex and difficult topic and from clinical and palliative care researchers in seeing beyond the 'cost' element of economics. It also needs sufficient targeted investment in research into the economics of palliative and end-of-life care: after all, financial and other incentive mechanisms apply as much to researchers and economists, as to service providers! Researchers and journals may want to explore ways to stimulate research and publication on these other aspects of economics in palliative and end-of-life care.
